Document Information


PMID 11228742  (  )
Title Activation of NF-kappa B by reactive oxygen intermediates in the nervous system.
Abstract Nuclear factor kappa B (NF-kappa B) is a transcription factor crucially involved in glial and neuronal function. NF-kappa B is ubiquitously distributed within the nervous system, and its inducible activity can be discerned from constitutive activity. Prototypic inducible NF-kappa B in the nervous system is composed of the DNA-binding subunits p50 and p65 complexed with an inhibitory I kappa B-alpha molecule. A number of signals from the cell surface can lead to rapid activation of NK-kappa B, thus releasing the inhibition by I kappa B. This activates translocation of NF-kappa B to the nucleus, where it binds to kappa B motifs of target genes and activates transcription. Previous findings have identified reactive oxygen intermediates (ROI) as a common denominator of NF-kappa B activating signals. More specifically, hydrogen peroxide (H2O2) might be used as second messenger in the NF-kappa B system, despite its cytotoxicity. Analysis of pathways leading to NF-kappa B activation in the nervous system has identified a number of ROI-dependent pathways such as cytokine- and neurotrophin-mediated activation, glutamatergic signal transduction, and various diseases with crucial ROI involvement (e.g., Alzheimer's disease, Parkinson's disease, experimental autoimmune encephalomyelitis, multiple sclerosis, amyotrophic lateral sclerosis, and injury). A number of NF-kappa B-specific target genes contribute to the production of ROI or are involved in detoxification of ROIs. In this review, possible mechanisms and regulatory pathways of ROI-mediated NF-kappa B activation are discussed. D-79104 Freiburg, Germany. kaltschm@uni-freiburg.edu

NOTE: Color highlight is limited to the abstract and SciMiner text-mining mode. If you see much more identified targets below from "Targets by SciMiner Summary" and "Targets by SciMiner Full list", they may have been identified from the full text.



Targets by SciMiner Summary

HUGO ID Symbol Target Name #Occur ActualStr
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)12nuclear factor kappa b | nf kappa b |
11919CD40CD40 molecule, TNF receptor superfamily member 51p50 |
16769GORASP1golgi reassembly stacking protein 1, 65kDa1p65 |
1033BDNFbrain-derived neurotrophic factor1neurotrophin |

 


Targets by SciMiner Full list

HUGO ID Symbol Name ActualStr Score FlankingText
11919CD40CD40 molecule, TNF receptor superfamily member 5p500.3in the nervous system is composed of the DNA-binding subunits p50 and p65 complexed with an inhibitory I kappa B-alpha molecule
16769GORASP1golgi reassembly stacking protein 1, 65kDap650.1nervous system is composed of the DNA-binding subunits p50 and p65 complexed with an inhibitory I kappa B-alpha molecule
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nf kappa b1.0activation of nf kappa b by reactive oxygen intermediates in the nervous system.
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nf kappa b1.0nuclear factor kappa b nf kappa b is a transcription factor crucially involved in glial and neuronal function.
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nuclear factor kappa b1.0nuclear factor kappa b nf kappa b is a transcription factor crucially involved in glial and neuronal function.
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nf kappa b1.0nf kappa b is ubiquitously distributed within the nervous system and its inducible activity can be discerned from constitutive activity.
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nf kappa b1.0prototypic inducible nf kappa b in the nervous system is composed of the dna binding subunits p50 and p65 complexed with an inhibitory i kappa b alpha molecule.
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nf kappa b1.0a number of signals from the cell surface can lead to rapid activation of nk kappa b thus releasing the inhibition by i kappa b. this activates translocation of nf kappa b to the nucleus where it binds to kappa b motifs of target genes and activates transcription.
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nf kappa b1.0previous findings have identified reactive oxygen intermediates roi as a common denominator of nf kappa b activating signals.
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nf kappa b1.0more specifically hydrogen peroxide h2o2 might be used as second messenger in the nf kappa b system despite its cytotoxicity.
1033BDNFbrain-derived neurotrophic factorneurotrophin1.0analysis of pathways leading to nf kappa b activation in the nervous system has identified a number of roi dependent pathways such as cytokine and neurotrophin mediated activation glutamatergic signal transduction and various diseases with crucial roi involvement e.g. alzheimer's disease parkinson's disease experimental autoimmune encephalomyelitis multiple
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nf kappa b1.0analysis of pathways leading to nf kappa b activation in the nervous system has identified a number of roi dependent pathways such as cytokine and neurotrophin mediated activation glutamatergic signal transduction and various diseases with cr
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nf kappa b1.0a number of nf kappa b specific target genes contribute to the production of roi or are involved in detoxification of rois.
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nf kappa b1.0in this review possible mechanisms and regulatory pathways of roi mediated nf kappa b activation are discussed.
7794NFKB1nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)nf kappa b1.0nf kappa b|oxidants|reactive oxygen species|